We're In The Business Of What Ought To Be.
Location: United States, Kansas, Overland Park
Employees: 1001-5000
Phone:+1 312-444-8000
Founded date: 1997
Investment Type: Venture Capital
Investment Stage: Series B
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 13.04.2023 | Tradier | tradier.com | $27.7M | Haiti, L'A... |
| 31.01.2023 | Colossal B... | colossal.com | $485M | United Sta... |
| 25.10.2021 | Thrasio | thras.io | $2.89B | United Sta... |
Mentions in press and media 20
| Date | Title | Description |
| 09.04.2025 | One of America’s richest self-made women urges entrepreneurs to see volatile stock markets as an ‘opportunity’ | Americans have been on edge this week as the stock market reacted to new tariffs from the Trump administration announced on April 2 and in effect Wednesday. It’s made an “always challenging” environment for founders and investors of small a... |
| 16.01.2025 | The Dawn of De-Extinction: Colossal Biosciences Rises to New Heights | In a world where extinction looms like a dark cloud, a beacon of hope has emerged. Colossal Biosciences, a Dallas-based startup, is rewriting the rules of biology. With a recent $200 million Series C funding round, the company has soared to... |
| 16.01.2025 | Colossal: $200 Million (Series C) Raised At $10.2 Billion Valuation For De-Extinction Technology | De-extinction company Colossal Biosciences announced $200 million in a Series C funding round by TWG Global, jointly led by Mark Walter and Thomas Tull. And Colossal’s additional strategic investors include funds such as USIT, Animal Capita... |
| 15.01.2025 | De-Extinction Startup Colossal Biosciences Hits Decacorn Status After $200M Raise | 4 Shares Email Facebook Twitter LinkedIn Colossal Biosciences, a de-extinction startup looking at ways to bring back the dodo bird and the woolly mammoth, raised a $200 million Series C at a $10.2 billion valuation. The new cash infusion ca... |
| 15.01.2025 | Colossal Raises $200M in Series C Funding | Colossal Biosciences, a Dallas, TX-based de-extinction company, raised $200M in Series C Funding. Backers included TWG Global. Other investors included USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, D... |
| 10.12.2024 | Cala Health's $50 Million Surge: A New Dawn for Tremor Therapy | Cala Health is making waves. The California-based company has just secured $50 million in a growth funding round. This isn't just a financial boost; it's a lifeline for those grappling with essential tremor. Cala Health specializes in bioel... |
| 09.12.2024 | Cala Health Closes $50M Financing | Cala Health, a San Mateo, CA-based non-invasive bioelectronic medicine company, raised $50M in funding. The round was led by Vertex Growth Fund and Nexus NeuroTech Ventures. Existing investors participated in the round, including Action Pot... |
| 09.12.2024 | Cala Health Raises $50M for Wearable Tremor Treatment | What You Should Know: – Cala Health, the non-invasive bioelectronic medicine leader, today announced it has raised a $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. – All existing Cala investors particip... |
| 09.12.2024 | Cala Health: Bioelectronic Medicine Leader Raises $50 Million (Growth Round) | Cala Health – a non-invasive bioelectronic medicine leader – announced it has raised the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. And all existing Cala investo... |
| 29.08.2024 | The AI Gold Rush: Investment and Infrastructure Shaping Tomorrow | The world is in the midst of an AI gold rush. Companies are scrambling to stake their claims in this burgeoning landscape. Two recent developments highlight this trend: Magnetar’s $235 million AI fund and CoreWeave’s partnership with EcoDat... |
Show more